630 related articles for article (PubMed ID: 30648737)
1. Calcitonin Gene-Related Peptide Antagonists in the Treatment of Episodic Migraine.
Yuan H; White CS; Silberstein SD
Clin Pharmacol Ther; 2019 May; 105(5):1121-1129. PubMed ID: 30648737
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
Hargreaves R; Olesen J
Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
[TBL] [Abstract][Full Text] [Related]
3. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
Maasumi K; Michael RL; Rapoport AM
Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
[TBL] [Abstract][Full Text] [Related]
4. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Edvinsson L; Haanes KA; Warfvinge K; Krause DN
Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
[TBL] [Abstract][Full Text] [Related]
5. Targeting of calcitonin gene-related peptide action as a new strategy for migraine treatment.
Kuzawińska O; Lis K; Cessak G; Mirowska-Guzel D; Bałkowiec-Iskra E
Neurol Neurochir Pol; 2016; 50(6):463-467. PubMed ID: 27553188
[TBL] [Abstract][Full Text] [Related]
6. Role of CGRP in Migraine.
Edvinsson L
Handb Exp Pharmacol; 2019; 255():121-130. PubMed ID: 30725283
[TBL] [Abstract][Full Text] [Related]
7. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention.
Caronna E; Alpuente A; Torres-Ferrus M; Pozo-Rosich P
Handb Clin Neurol; 2024; 199():107-124. PubMed ID: 38307640
[TBL] [Abstract][Full Text] [Related]
8. CGRP receptor antagonism and migraine therapy.
Edvinsson L; Warfvinge K
Curr Protein Pept Sci; 2013 Aug; 14(5):386-92. PubMed ID: 23745702
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
Durham PL; Vause CV
CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
[TBL] [Abstract][Full Text] [Related]
10. Erenumab in the treatment of migraine.
Jain S; Yuan H; Spare N; Silberstein SD
Pain Manag; 2018 Nov; 8(6):415-426. PubMed ID: 30235976
[TBL] [Abstract][Full Text] [Related]
11. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
Chen ST; Wu JW
Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
[TBL] [Abstract][Full Text] [Related]
12. Targeting calcitonin gene-related peptide: a new era in migraine therapy.
Charles A; Pozo-Rosich P
Lancet; 2019 Nov; 394(10210):1765-1774. PubMed ID: 31668411
[TBL] [Abstract][Full Text] [Related]
13. CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
Favoni V; Giani L; Al-Hassany L; Asioli GM; Butera C; de Boer I; Guglielmetti M; Koniari C; Mavridis T; Vaikjärv M; Verhagen I; Verzina A; Zick B; Martelletti P; Sacco S;
J Headache Pain; 2019 Mar; 20(1):27. PubMed ID: 30866804
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale.
Cohen F; Yuan H; Silberstein SD
BioDrugs; 2022 May; 36(3):341-358. PubMed ID: 35476215
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin Gene-Related Peptide (CGRP) Antagonists and Their Use in Migraines.
Henson B; Hollingsworth H; Nevois E; Herndon C
J Pain Palliat Care Pharmacother; 2020 Mar; 34(1):22-31. PubMed ID: 31763951
[TBL] [Abstract][Full Text] [Related]
16. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
17. Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.
Link AS; Kuris A; Edvinsson L
J Headache Pain; 2008 Feb; 9(1):5-12. PubMed ID: 18217201
[TBL] [Abstract][Full Text] [Related]
18. CGRP receptor antagonists: a new choice for acute treatment of migraine?
Durham PL
Curr Opin Investig Drugs; 2004 Jul; 5(7):731-5. PubMed ID: 15298069
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin Gene-Related Peptide Antagonists for the Prevention of Migraine: Highlights From Pivotal Studies and the Clinical Relevance of This New Drug Class.
Arca K; Reynolds J; Sands KA; Shiue HJ
Ann Pharmacother; 2020 Aug; 54(8):795-803. PubMed ID: 32019317
[No Abstract] [Full Text] [Related]
20. Calcitonin gene-related peptide (CGRP): a new target for migraine.
Russo AF
Annu Rev Pharmacol Toxicol; 2015; 55():533-52. PubMed ID: 25340934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
